Polaris Partners

North America, Massachusetts, United States, Boston

Description

Polaris Partners is an investment firm that invests in healthcare and biotechnology companies.

Investor Profile

Polaris Partners has made 674 investments, with 17 in the past 12 months and 26% as lead.

Stage Focus

Series B (25%)
Series A (24%)
Series C (16%)
Series Unknown (16%)
Seed (8%)
Series D (6%)
Series E (2%)
Private Equity (2%)
Post Ipo Equity (1%)
Series F (1%)

Country Focus

United States (94%)
Singapore (1%)
Ireland (1%)
The Netherlands (1%)
United Kingdom (1%)
Israel (1%)

Industry Focus

Health Care
Biotechnology
Medical
Software
Therapeutics
Pharmaceutical
Information Technology
Medical Device
Enterprise Software
Saas

FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Polaris Partners frequently co-invest with?

OrbiMed

North America, New York, United States, New York

Co-Investments: 28

Alexandria Venture Investments

North America, California, United States, Pasadena

Co-Investments: 22

General Catalyst

North America, Massachusetts, United States, Cambridge

Co-Investments: 22

Google Ventures

North America, California, United States, Mountain View

Co-Investments: 39

Intersouth Partners

North America, North Carolina, United States, Durham

Co-Investments: 24

Lux Capital

North America, New York, United States, New York

Co-Investments: 26

Venrock

North America, California, United States, Palo Alto

Co-Investments: 27

Flagship Pioneering

North America, Massachusetts, United States, Cambridge

Co-Investments: 49

Invus

North America, New York, United States, New York

Co-Investments: 23

ARCH Venture Partners

North America, Illinois, United States, Chicago

Co-Investments: 54

Which angels does Polaris Partners often collaborate with?

Richard Kresch

North America, New York, United States, New York

Shared Deals: 3

Nicolas Berggruen

North America, California, United States, Los Angeles

Shared Deals: 2

Bill Gates

North America, Washington, United States, Seattle

Shared Deals: 3

Timothy A. Springer

North America, Massachusetts, United States, Cambridge

Shared Deals: 9

Benjamin Ling

North America, California, United States, Menlo Park

Shared Deals: 2

Garry Tan

North America, California, United States, San Francisco

Shared Deals: 2

Franklin Berger

North America, New York, United States, New York

Shared Deals: 3

Arjun Sethi

North America, California, United States, San Francisco

Shared Deals: 2

Never WorkedHere

North America, Minnesota, United States, Minneapolis

Shared Deals: 4

Dalton Caldwell

North America, California, United States, San Francisco

Shared Deals: 2

What are some of recent deals done by Polaris Partners?

Auron Therapeutics

Newton, Massachusetts, United States

Auron aims to cure cancer therapeutics from cell killing to transformation of malignant cells into more normal functioning cells.

BiotechnologyHealth CareTherapeutics

Series BFeb 4, 2025

Amount Raised: $27,000,000

Leyden Labs

Amsterdam, Noord-Holland, The Netherlands

Leyden Labs provides a platform that targets commonalities of viral families to protect humanity from known and future viruses.

BiotechnologyLife ScienceTherapeutics

Series BJan 9, 2025

Amount Raised: $70,000,000

FIRE1

Dublin, Dublin, Ireland

FIRE1 and is based in Dublin, Ireland, will focus on developing novel therapeutic devices.

BiotechnologyHealth CareMedical DeviceTherapeutics

Series UnknownJan 7, 2025

Amount Raised: $120,000,000

Noema Pharma

Basel, Basel-Stadt, Switzerland

Noema Pharma is a biotech company that develops therapies to address disabling symptoms in conditions of the brain and nervous system.

BiotechnologyMedicalPharmaceutical

Series BDec 11, 2024

Amount Raised: $30,567,953

TRex Bio

South San Francisco, California, United States

TRex Bio is a biotechnology company that treats diseases like cancer, fibrotic by studying human tissues.

BioinformaticsBiopharmaBiotechnology

Series BNov 13, 2024

Amount Raised: $84,000,000

Sunbird Bio

Singapore, Central Region, Singapore

Sunbird Bio is a diagnostics platform developer that aims to give molecular diagnostics with faster outcomes.

BiotechnologyHealth CareHealth DiagnosticsMedical

Series UnknownOct 16, 2024

Amount Raised: $14,000,000

Candid Therapeutics

San Diego, California, United States

Candid Therapeutics is a biotechnology company that focuses on the treatment of a range of immunological conditions.

BiotechnologyProduct ResearchTherapeutics

Series ASep 9, 2024

Amount Raised: $370,000,000

Noetik

South San Francisco, California, United States

Noetik is an AI-native biotechnology company.

BiotechnologyLife Science

Series AAug 28, 2024

Amount Raised: $40,000,000

BeMe Health

Miami, Florida, United States

Be Me Health is a mobile platform that focuses on the mental health and emotional well-being of teens.

Mental HealthMobileWellnessYoung Adults

SeedAug 22, 2024

Amount Raised: $12,500,000

BeMe Health

Miami, Florida, United States

Be Me Health is a mobile platform that focuses on the mental health and emotional well-being of teens.

Mental HealthMobileWellnessYoung Adults

Series AAug 22, 2024

Amount Raised: $12,500,000

Polaris Partners

Description

Investor Profile

Stage Focus

Country Focus

Industry Focus

Frequently Asked Questions

Who does Polaris Partners frequently co-invest with?

Which angels does Polaris Partners often collaborate with?

What are some of recent deals done by Polaris Partners?

Ready to Raise Capital?

Pages

Free tools